Literature DB >> 25511758

Cardiovascular disease in CKD in 2014: new insights into cardiovascular risk factors and outcomes.

Pantelis A Sarafidis1, George L Bakris2.   

Abstract

Chronic kidney disease (CKD) is an established independent risk factor for increased cardiovascular events and cardiovascular mortality. During 2014, several research efforts focused on clarifying the complex pathophysiology, assessing the prognostic associations and improving the treatment of cardiovascular disease in patients with CKD.

Entities:  

Mesh：

Year:  2014        PMID： 25511758     DOI： 10.1038/nrneph.2014.242

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


  9 in total

1.  Proteinuria Increases Plasma Phosphate by Altering Its Tubular Handling.

Authors:  Sophie de Seigneux; Marie Courbebaisse; Joseph M Rutkowski; Alexandra Wilhelm-Bals; Marie Metzger; Stellor Nlandu Khodo; Udo Hasler; Hassib Chehade; Eva Dizin; Arezoo Daryadel; Bénedicte Stengel; E Girardin; Dominique Prié; Carsten A Wagner; Philipp E Scherer; Pierre-Yves Martin; Pascal Houillier; Eric Feraille
Journal:  J Am Soc Nephrol       Date:  2014-10-27       Impact factor: 10.121

2.  Hypertension in hemodialysis patients treated with atenolol or lisinopril: a randomized controlled trial.

Authors:  Rajiv Agarwal; Arjun D Sinha; Maria K Pappas; Terri N Abraham; Getachew G Tegegne
Journal:  Nephrol Dial Transplant       Date:  2014-01-06       Impact factor: 5.992

3.  Evaluation of a novel brachial cuff-based oscillometric method for estimating central systolic pressure in hemodialysis patients.

Authors:  Pantelis A Sarafidis; Panagiotis I Georgianos; Antonios Karpetas; Athanasios Bikos; Linda Korelidou; Maria Tersi; Dimitrios Divanis; Georgios Tzanis; Konstantinos Mavromatidis; Vassilios Liakopoulos; Pantelis E Zebekakis; Anastasios Lasaridis; Athanase D Protogerou
Journal:  Am J Nephrol       Date:  2014-10-11       Impact factor: 3.754

4.  Cardiovascular protection by β-blockade in hypertensive haemodialysis patients: the Hypertension in Haemodialysis Patients Treated With Atenolol or Lisinopril (HDPAL) trial.

Authors:  Carmine Zoccali; Francesca Mallamaci
Journal:  Nephrol Dial Transplant       Date:  2014-03       Impact factor: 5.992

5.  Obstructive sleep apnea in incremental hemodialysis: determinants, consequences, and impact on survival.

Authors:  Murugan Sivalingam; Indranil Chakravorty; Sarah Mouatt; Ken Farrington
Journal:  Hemodial Int       Date:  2012-08-13       Impact factor: 1.812

6.  Differences between office and 24-hour blood pressure control in hypertensive patients with CKD: A 5,693-patient cross-sectional analysis from Spain.

Authors:  Manuel Gorostidi; Pantelis A Sarafidis; Alejandro de la Sierra; Julian Segura; Juan J de la Cruz; Jose R Banegas; Luis M Ruilope
Journal:  Am J Kidney Dis       Date:  2013-05-18       Impact factor: 8.860

7.  Assessment of achieved clinic and ambulatory blood pressure recordings and outcomes during treatment in hypertensive patients with CKD: a multicenter prospective cohort study.

Authors:  Roberto Minutolo; Francis B Gabbai; Rajiv Agarwal; Paolo Chiodini; Silvio Borrelli; Vincenzo Bellizzi; Felice Nappi; Giovanna Stanzione; Giuseppe Conte; Luca De Nicola
Journal:  Am J Kidney Dis       Date:  2014-07-28       Impact factor: 8.860

8.  Snoring amplifies the risk of heart failure and mortality in dialysis patients.

Authors:  Claudia Torino; Francesco Mattace-Raso; Jan L C M van Saase; Graziella D'Arrigo; Rocco Tripepi; Giovanni Luigi Tripepi; Maurizio Postorino; Francesca Mallamaci; Carmine Zoccali
Journal:  Am J Nephrol       Date:  2014-06-12       Impact factor: 3.754

Review 9.  Assessment and management of hypertension in patients on dialysis.

Authors:  Rajiv Agarwal; Joseph Flynn; Velvie Pogue; Mahboob Rahman; Efrain Reisin; Matthew R Weir
Journal:  J Am Soc Nephrol       Date:  2014-04-03       Impact factor: 10.121
  9 in total
  5 in total

Review 1.  The Ebb and Flow of Echocardiographic Cardiac Function Parameters in Relationship to Hemodialysis Treatment in Patients with ESRD.

Authors:  Charalampos Loutradis; Pantelis A Sarafidis; Christodoulos E Papadopoulos; Aikaterini Papagianni; Carmine Zoccali
Journal:  J Am Soc Nephrol       Date:  2018-03-28       Impact factor: 10.121

2.  Estimated Glomerular Filtration Rate, Activation of Cardiac Biomarkers and Long-Term Cardiovascular Outcomes: A Population-Based Cohort.

Authors:  Shravya Vinnakota; Christopher G Scott; Richard J Rodeheffer; Horng H Chen
Journal:  Mayo Clin Proc       Date:  2019-10-23       Impact factor: 7.616

3.  County-level air quality and the prevalence of diagnosed chronic kidney disease in the US Medicare population.

Authors:  Jennifer Bragg-Gresham; Hal Morgenstern; William McClellan; Sharon Saydah; Meda Pavkov; Desmond Williams; Neil Powe; Delphine Tuot; Raymond Hsu; Rajiv Saran
Journal:  PLoS One       Date:  2018-07-31       Impact factor: 3.240

4.  Altered lipid metabolism in the aging kidney identified by three layered omic analysis.

Authors:  Fabian Braun; Markus M Rinschen; Valerie Bartels; Peter Frommolt; Bianca Habermann; Jan H J Hoeijmakers; Björn Schumacher; Martijn E T Dollé; Roman-Ulrich Müller; Thomas Benzing; Bernhard Schermer; Christine E Kurschat
Journal:  Aging (Albany NY)       Date:  2016-03       Impact factor: 5.682

5.  Fibroblast growth factor 23 expression in human calcified vascular tissues.

Authors:  Javier Donate-Correa; Ernesto Martín-Núñez; Carolina Hernández-Carballo; Carla Ferri; Víctor G Tagua; Alejandro Delgado-Molinos; Ángel López-Castillo; Sergio Rodríguez-Ramos; Purificación Cerro-López; Victoria Castro López-Tarruella; Raquel Felipe-García; Miguel A Arévalo-Gomez; Nayra Pérez-Delgado; Carmen Mora-Fernández; Juan F Navarro-González
Journal:  Aging (Albany NY)       Date:  2019-09-22       Impact factor: 5.682
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.